Clinical Trials · NCT00477581
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 102
- Start date
- May 2007
- Locations
- 19 sites, United States
- Primary endpoint
- Effect of Exenatide on postprandial glucose